These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 22690069)

  • 21. Gut--liver axis: the impact of gut microbiota on non alcoholic fatty liver disease.
    Compare D; Coccoli P; Rocco A; Nardone OM; De Maria S; Cartenì M; Nardone G
    Nutr Metab Cardiovasc Dis; 2012 Jun; 22(6):471-6. PubMed ID: 22546554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia.
    Fukui H
    World J Hepatol; 2015 Mar; 7(3):425-42. PubMed ID: 25848468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gut microbiota and probiotics in chronic liver diseases.
    Cesaro C; Tiso A; Del Prete A; Cariello R; Tuccillo C; Cotticelli G; Del Vecchio Blanco C; Loguercio C
    Dig Liver Dis; 2011 Jun; 43(6):431-8. PubMed ID: 21163715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intestinal Permeability Is a Mechanical Rheostat in the Pathogenesis of Liver Cirrhosis.
    Nishimura N; Kaji K; Kitagawa K; Sawada Y; Furukawa M; Ozutsumi T; Fujinaga Y; Tsuji Y; Takaya H; Kawaratani H; Moriya K; Namisaki T; Akahane T; Fukui H; Yoshiji H
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of Probiotics in Nonalcoholic Fatty Liver Disease: A New Insight into Therapeutic Strategies.
    Meroni M; Longo M; Dongiovanni P
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31689910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amelioration of non-alcoholic steatohepatitis by Qushi Huayu decoction is associated with inhibition of the intestinal mitogen-activated protein kinase pathway.
    Leng J; Huang F; Hai Y; Tian H; Liu W; Fang Y; Hu Y; Peng J
    Phytomedicine; 2020 Jan; 66():153135. PubMed ID: 31790895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preventing Bacterial Translocation in Patients with Leaky Gut Syndrome: Nutrition and Pharmacological Treatment Options.
    Twardowska A; Makaro A; Binienda A; Fichna J; Salaga M
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obesity and NAFLD: the role of bacteria and microbiota.
    Duseja A; Chawla YK
    Clin Liver Dis; 2014 Feb; 18(1):59-71. PubMed ID: 24274865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut-liver axis and sensing microbes.
    Szabo G; Bala S; Petrasek J; Gattu A
    Dig Dis; 2010; 28(6):737-44. PubMed ID: 21525758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction of endotoxin attenuates liver fibrosis through suppression of hepatic stellate cell activation and remission of intestinal permeability in a rat non-alcoholic steatohepatitis model.
    Douhara A; Moriya K; Yoshiji H; Noguchi R; Namisaki T; Kitade M; Kaji K; Aihara Y; Nishimura N; Takeda K; Okura Y; Kawaratani H; Fukui H
    Mol Med Rep; 2015 Mar; 11(3):1693-700. PubMed ID: 25421042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacterial translocation (BT) in cirrhosis.
    Wiest R; Garcia-Tsao G
    Hepatology; 2005 Mar; 41(3):422-33. PubMed ID: 15723320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leaky Gut and Gut-Liver Axis in Liver Cirrhosis: Clinical Studies Update.
    Fukui H
    Gut Liver; 2021 Sep; 15(5):666-676. PubMed ID: 33071239
    [TBL] [Abstract][Full Text] [Related]  

  • 33.  Gut microbiota and nonalcoholic fatty liver disease.
    Machado MV; Cortez-Pinto H
    Ann Hepatol; 2012; 11(4):440-9. PubMed ID: 22700625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methods to determine intestinal permeability and bacterial translocation during liver disease.
    Wang L; Llorente C; Hartmann P; Yang AM; Chen P; Schnabl B
    J Immunol Methods; 2015 Jun; 421():44-53. PubMed ID: 25595554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Myosin light chain kinase involved in change of intestinal mucosal barrier function in nonalcoholic steatohepatitis mice model].
    Zhang Y; Li J; Chi Y; Li M; Pan X; Zhang Q; He X; Liu Y
    Zhonghua Nei Ke Za Zhi; 2015 May; 54(5):434-8. PubMed ID: 26080824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Role of gut-liver-immune axis in the pathogenesis of nonalcoholic steatohepatitis].
    Shao L; Song Y; Shi JP
    Zhonghua Gan Zang Bing Za Zhi; 2021 Jun; 29(6):505-509. PubMed ID: 34225424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Morphine induces bacterial translocation in mice by compromising intestinal barrier function in a TLR-dependent manner.
    Meng J; Yu H; Ma J; Wang J; Banerjee S; Charboneau R; Barke RA; Roy S
    PLoS One; 2013; 8(1):e54040. PubMed ID: 23349783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gut microbiota-related complications in cirrhosis.
    Gómez-Hurtado I; Such J; Sanz Y; Francés R
    World J Gastroenterol; 2014 Nov; 20(42):15624-31. PubMed ID: 25400446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gut flora and bacterial translocation in chronic liver disease.
    Almeida J; Galhenage S; Yu J; Kurtovic J; Riordan SM
    World J Gastroenterol; 2006 Mar; 12(10):1493-502. PubMed ID: 16570339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bile and circulating HMGB1 contributes to systemic inflammation in obstructive jaundice.
    Yang R; Zhu S; Pischke SE; Haugaa H; Zou X; Tonnessen TI
    J Surg Res; 2018 Aug; 228():14-19. PubMed ID: 29907203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.